TrialBMC cancer2018

The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale).

Michele Guida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.